A unique new flexible and stretchable device, worn against the skin and capable of producing electrical energy by transforming the compounds present in sweat, was recently developed and patented by CNRS researchers from l’Université Grenoble Alpes and UC San Diego (USA). This cell is already capable of continuously lighting an LED, opening new avenues for the development of wearable electronics powered by autonomous and environmentally friendly biodevices.
This research was published in Advanced Functional Materials on September 25, 2019.
The potential uses for wearable electronic devices continue to increase, especially for medical and athletic monitoring. Such devices require the development of a reliable and efficient energy source that can easily be integrated into the human body. Using “biofuels” present in human organic liquids has long been a promising avenue.
Scientists from the Département de chimie moléculaire (CNRS/Université Grenoble Alpes), who specialize in bioelectrochemistry, decided to collaborate with an American team from UC San Diego, who are experts in nanomachines, biosensors, and nanobioelectronics. Together they developed a flexible conductive material consisting of carbon nanotubes, crosslinked polymers, and enzymes joined by stretchable connectors that are directly printed onto the material through screen-printing1.
The biofuel cell, which follows deformations in the skin, produces electrical energy through the reduction of oxygen and the oxidation of the lactate present in perspiration.
Once applied to the arm, it uses a voltage booster to continuously power an LED. It is relatively simple and inexpensive to produce, with the primary cost being the production of the enzymes that transform the compounds found in sweat. The researchers are now seeking to amplify the voltage provided by the biofuel cell in order to power larger portable devices.
The Latest on: Biofuel cell
via Google News
The Latest on: Biofuel cell
- Inside Annovis Bio's $13.8 million IPOon January 31, 2020 at 9:48 am
Annovis Bio CEO Maria Maccecchini reveals why the company went public and tells the story behind the company's IPO.
- Annovis Bio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shareson January 31, 2020 at 8:46 am
BERWYN, Pa., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE American: ANVS), a clinical stage, drug platform company addressing ...
- Controllable Display of Sequential Enzymes on Yeast Surface with Enhanced Biocatalytic Activity toward Efficient Enzymatic Biofuel Cellson January 30, 2020 at 12:46 pm
Institute for Chemical Biology & Biosensing, and College of Life Sciences, Qingdao University, 308 Ningxia Road, Qingdao 266071, P. R. China Qingdao Institute of Bioenergy & Bioprocess Technology, ...
- Utilization of tannery wastewater for biofuel production: New insights on microalgae growth and biomass productionon January 30, 2020 at 2:26 am
Recently, microalgae cultivation for biofuel production is considered as a green technology for the microalgae ... Samples were taken for the three strains on daily basis to measure sugar, chlorophyll ...
- Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteinson January 29, 2020 at 4:53 pm
Now the company, Berwyn, PA-based Annovis Bio, has raised $12 million in an initial public offering to advance clinical ... High levels of neurotoxic proteins impair communication between and within ...
- Annovis Bio is latest Philly-area biotech firm to sell shares before productson January 29, 2020 at 8:42 am
Annovis is the latest Philly-area biotech developer to sell shares to the public since last fall, when radiation-sickness drug developer Galera Therapeutics (based in Malvern), the T-cell ...
- At A CAGR of 12%, Cell Culture Protein Surface Coating Market will Attain an Impressive Growth During Forecast Periods 2018-2028on January 28, 2020 at 3:34 am
Cell Culture Protein Surface Coating Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And ...
- Bio implants Market 2020 Analysis Research and Development Forecast by 2025on January 28, 2020 at 2:59 am
New York, January 28, 2020: Bio-implants are bioengineered products, employ in human living cells or in tissues with the support of active agents used to replicate certain physiological function. The ...
- Quench Bio Springs From Atlas With $50M for a New Take on Inflammationon January 27, 2020 at 4:37 pm
Cells die all the time in a controlled manner that’s perfectly normal. But the way cells die matters. Sometimes cell death is violent, sparking inflammation believed to contribute to disease. Quench ...
- HPV Vax Efficacy Questioned; Bio$imilar Market Effect$; 'Lighting Up' Cells May Cut Toxicityon January 23, 2020 at 10:31 am
An analysis of a dozen published studies of human papillomavirus vaccines raised questions about the vaccines' ability to prevent cervical cancer. (Journal of the Royal Society of Medicine) ...
via Bing News